Enbridge Inc (ENB) · Sep 14, 2026 · Share issuance
C$3B share issuance — 44.735M shares issued at C$66.85; gross proceeds approximately C$3.0B
Enbridge completed its bought-deal equity raise, providing roughly C$3 billion for announced acquisitions and future growth while adding shareholder dilution.
Enbridge is expanding its North American liquids and gas infrastructure while executing a secured growth backlog exceeding C$39 billion and targeting leverage of 4.5x–5.0x debt to EBITDA. This filing completes a financing that was already disclosed, rather than changing the strategy. Enbridge issued 44,735,000 common shares on September 14, 2026. 〔0〕 The offering had already been announced on September 9, including the potential full exercise of the over-allotment option, so the closing itself is confirmation rather than a fresh surprise.
| Item | Filing figure |
|---|---|
| Common shares issued | 44.735 million |
| Offer price | C$66.85 per share |
| Gross proceeds, including full over-allotment | Approximately C$3.0 billion |
The financing supports growth but shifts more of the burden onto equity. The filing says the proceeds will partially fund announced acquisitions and provide flexibility for future growth; that matches Enbridge's stated capital-allocation plan and does not add a new project or improve operating performance by itself. The completed raise therefore strengthens funding flexibility for the acquisition-led expansion, while existing shareholders absorb dilution.
Bottom line: This is a completed, previously announced financing—not a new strategic development. It funds Enbridge's acquisition and growth program, but the business impact depends on the returns from those assets rather than on the equity raise itself.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!